CIK 0001006028 · Non-accelerated filer<br>Smaller reporting company
PURE BIOSCIENCE, INC.
Sign in to watch- Ticker
- PURE
- Exchange
- OTC
- Industry
- Miscellaneous Chemical Products
- FY end
- Jul 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330530289
- Phone
- 619-596-8600
- Business address
- 771 JAMACHA ROAD #512, EL CAJON, CA, 92019
- Former names
- PURE BIOSCIENCE, INNOVATIVE MEDICAL SERVICES
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-30 | Rendall David Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2022-09-30 | Taylor Kristin Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2022-09-30 | Myers Thomas Richard Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2022-09-30 | Myers Thomas Richard Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2022-09-30 | Lee Tom Y Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2022-09-30 | Lee Tom Y Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2022-09-30 | Chen Ivan Director | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2022-07-15 | Rendall David Director | Grant or award | +325,000 | $0.15 | $49K | 402,371 |
| 2022-07-15 | Lee Tom Y Chief Executive Officer | Grant or award | +15,741,666 | $0.15 | $2.4M | 29,143,617 |
| 2022-07-15 | Lee Tom Y Chief Executive Officer | Grant or award | +6,000,000 | $0.15 | $900K | 6,000,000 |
| 2022-07-15 | Chen Ivan Director | Grant or award | +300,000 | $0.15 | $45K | 750,000 |
| 2022-03-21 | Lee Tom Y Chief Executive Officer | Purchase | +185,000 | $0.20 | $37K | 4,951,843 |
| 2022-03-17 | Lee Tom Y Chief Executive Officer | Purchase | +13,250 | $0.18 | $2K | 4,766,843 |
| 2022-03-16 | Lee Tom Y Chief Executive Officer | Purchase | +21,227 | $0.18 | $4K | 4,753,593 |
| 2021-06-18 | Rendall David Director | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2021-06-18 | Taylor Kristin Director | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2021-06-18 | Myers Thomas Richard Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2021-06-18 | Myers Thomas Richard Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2021-06-18 | Lee Tom Y Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2021-06-18 | Lee Tom Y Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 |
Page 2 of 9 · 172 trades